Unknown

Dataset Information

0

Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era.


ABSTRACT: We measured severe acute respiratory syndrome coronavirus 2 immunoglobulin G responses in 67 patients with hematological malignancies after 2 messenger RNA vaccine doses. Forty-six percent were nonresponders; patients with B-cell chronic lymphocytic leukemia were at highest risk (77% nonresponders). Patients with hematological malignancies should continue wearing masks and socially distancing. Studies of revaccination, boosters, and humoral immune correlates of protection are needed.

SUBMITTER: Agha ME 

PROVIDER: S-EPMC8320282 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7565788 | biostudies-literature
| S-EPMC9933941 | biostudies-literature
| S-EPMC8295014 | biostudies-literature
| S-EPMC8763959 | biostudies-literature
| S-EPMC7033457 | biostudies-literature
| S-EPMC8575416 | biostudies-literature
| S-EPMC8639290 | biostudies-literature
| S-EPMC8507598 | biostudies-literature
2024-06-22 | PXD043213 | Pride
| S-EPMC4277117 | biostudies-literature